NCT03770273 2024-12-17Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic MastocytosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed21 enrolled 13 charts